XML 77 R39.htm IDEA: XBRL DOCUMENT v3.3.1.900
Share-Based Compensation (Tables)
12 Months Ended
Jan. 02, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Number and Weighted Average Exercise Price of Options Issued and Outstanding under All Stock Option Plans
number and weighted-average exercise price of stock options issued and outstanding under all stock plans, is presented below (in thousands, except for exercise price):
 
Year ended
January 2,
2016
 
Year ended
January 3,
2015
 
Year ended
December 28,
2013
 
Shares
 
Average
Exercise
Price
 
Shares
 
Average
Exercise
Price
 
Shares
 
Average
Exercise
Price
Options outstanding, beginning of period
9,956

 
$
23.59

 
8,911

 
$
22.76

 
8,368

 
$
22.78

Granted
914

 
36.18

 
1,887

 
24.83

 
1,653

 
21.17

Canceled
(218
)
 
24.33

 
(416
)
 
24.46

 
(795
)
 
24.53

Expired

 

 

 

 

 

Exercised
(1,450
)
 
19.54

 
(426
)
 
10.95

 
(315
)
 
10.49

Options outstanding, end of period
9,202

 
$
25.46

 
9,956

 
23.59

 
8,911

 
$
22.76

Options exercisable, end of period
5,609

 
$
24.72

 
5,859

 
$
23.63

 
5,188

 
$
22.69

Number and Weighted Average Exercise Price of Outstanding and Exercisable Options
The number and weighted-average exercise price of outstanding and exercisable stock options segregated by exercise price ranges (in thousands, except range of exercise prices and remaining contractual life) were as follows:
 
Year ended
January 2,
2016
 
Year ended
January 3,
2015
 
Options Outstanding
 
Options
Exercisable
 
Options Outstanding
 
Options
Exercisable
Range of Exercise Prices
Number of
Options
 
Average
Remaining
Contractual
Life
 
Number of
Options
 
Number of
Options
 
Average
Remaining
Contractual
Life
 
Number of
Options
$2.75 to $4.00

 
0
 

 
67

 
0.31
 
67

$4.01 to $12.00
304

 
0.69
 
304

 
639

 
1.44
 
639

$12.01 to $16.00
450

 
1.37
 
450

 
539

 
2.37
 
539

$16.01 to $23.98
3,698

 
6.59
 
1,867

 
4,256

 
7.58
 
1,580

$23.99 to $28.99
2,033

 
5.72
 
1,297

 
2,426

 
6.54
 
1,320

$29.00 to $31.99
1,822

 
4.20
 
1,429

 
1,744

 
4.46
 
1,435

$32.00 to $38.30
215

 
7.06
 
75

 
97

 
3.87
 
92

$38.31 to $41.51
560

 
7.10
 
187

 
188

 
3.40
 
187

$41.52 to $43.76
120

 
9.87
 

 

 
0
 

     Total
9,202

 
5.56
 
5,609

 
9,956

 
5.94
 
5,859

Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]
A summary of unvested RSU award activity is presented below (in thousands) except for per share amounts:
 
Year ended
January 2,
2016
 
Year ended
January 3,
2015
 
Year ended
December 28,
2013
 
Units
 
Weighted Average Grant
 Date Fair Value
 
Units
 
Weighted Average Grant
 Date Fair Value
 
Units
 
Weighted Average Grant
 Date Fair Value
RSUs outstanding, beginning of period

 
$

 

 
$

 

 
$

Granted
2,703

 
41.45

 

 

 

 

Canceled

 

 

 

 

 

Expired

 

 

 

 

 

Vested

 

 

 

 

 

RSUs outstanding, end of period
2,703

 
$
41.45

 

 
$

 

 
$

Range of Assumptions Used and Resulting Weighted-Average Fair Value of Options Granted at Date of Grant
The range of assumptions used and the resulting weighted-average fair value of stock options granted at the date of grant were as follows:
 
Year ended
January 2,
2016
 
Year ended
January 3,
2015
 
Year ended
December 28,
2013
Risk-free interest rate
1.3% to 1.9%
 
1.4% to 1.9%
 
0.7% to 1.8%
Expected term
5.5 years to 5.7 years
 
5.1 years to 5.5 years
 
5.1 years to 5.5 years
Estimated volatility
32.0% to 37.4%
 
31.7% to 36.5%
 
31.2% to 39.6%
Expected dividends
0%
 
0%
 
0%
Weighted-average fair value of options granted
$12.20 per share
 
$7.85 per share
 
$7.53 per share
Total Share-Based Compensation Expense Included in Consolidated Statements of Comprehensive Income
The following table presents the total share-based compensation expense that is included in each functional line item of the consolidated statements of operations (in thousands):
 
Year ended
January 2,
2016
 
Year ended
January 3,
2015
 
Year ended
December 28,
2013
Cost of goods sold
$
348

 
$
436

 
$
354

Selling, general and administrative
8,139

 
8,812

 
9,407

Research and development
2,338

 
1,757

 
1,913

     Total
$
10,825

 
$
11,005

 
$
11,674